Plasma semicarbazide-sensitive amine oxidase in stroke

European Neurology

Volumn 41, Issue 1, 1999, Pages 20-23

  Garpenstrand, Håkan ^a   Ekblom, Jonas ^a   Von Arbin, Magnus ^b   Oreland, Lars ^a   Murray, Veronica ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

Author keywords

Cerebrovascular disorder; Embolism; Semicarbazide sensitive amine oxidase; Thrombosis

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING);

ADULT; AGED; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; BRAIN EMBOLISM; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENDOTHELIUM LESION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; STROKE; VASCULAR TISSUE;

AGED; AGED, 80 AND OVER; AMINE OXIDASE (COPPER-CONTAINING); ARTERIOSCLEROSIS; CEREBROVASCULAR DISORDERS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; FORMALDEHYDE; HUMANS; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; SEMICARBAZIDES;

EID: 0032897470     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007993     Document Type: Article

References (25)

1. Lewinsohn R: Mammalian monoamine-oxidizing enzymes, with special reference to benzylamine oxidase in human tissues. Braz J Med Biol Res 1984;17:223-256.
2. Lyles GA, Chalmers J: The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol 1992;43:1409-1414.
3. Precious E, Gunn CE, Lyles GA: Deamination of methylamine by semicarbazide-sensitive amine oxidase in human unbilical artery and rat aorta. Biochem Pharmacol 1988;37:707-713.
4. Coelho H, Azavedo M, Manso C: Inhibitory effect of drugs used in the treatment of Parkinson's disease on plasma monoamine oxidase activity. J Neural Transm 1985;61:271-277.
5. Boomsma F, van den Meiracker A, Man in't Veld A, Schalekamp M: Contrasting effects of peripheral decarboxylase inhibitors on plasma activity of aromatic-L-amino acid decarboxylase and semicarbazide-sensitive amine oxidase in Parkinson's disease. Life Sci 1995;57:1753-1759.
6. Lyles GA: Substrate-specificity of mammalian tissue-bound semicarbazide-sensitive amine oxidase. Prog Brain Res 1995;106:293-303.
7. Hysmith RM, Boor PJ: In vitro expression of benzylamine oxidase activity in cultured porcine smooth muscle cells. J Cardiovasc Pharmacol 1987;9:668-674.
8. McEwen CM Jr, Castell DO: Abnormalities of serum monoamine oxidase in chronic liver disease. J Lab Clin Med 1967;70:36-47.
9. Buffoni F, Ignesti G, Pirisino R, Cortesini C: Platelet monoamine oxidase, plasma benzylamine oxidase and liver mixed function oxidase in cirrhotic patients. Med Biol 1977;55: 109-111.
10. Nilsson SE, Tiding N, Tufvesson G: Serum monoamine oxidase (MAO) in diabetes mellitus and some other internal diseases. Acta Med Scand 1968;184:105-108.
11. Boomsma F, Derkx FMH, van den Meiracker AH, Man in't Veld AJ, Schalekamp MADH: Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci 1995;88:675-679.
12. McEwen CM, Harrison DS: Abnormalities of serum monoamine oxidase in chronic congestive heart failure. J Lab Clin Med 1965;65: 546-559.
13. Boomsma F, van Veldhuisen DJ, de Kam PJ, Man in't Veld AJ, Mosterd A, Lie KI. Schalekamp MADH: Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res 1997;33: 387-391.
14. Yu PH, Zuo DM: Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Diabetes 1993;42:594-603.
15. Ishizaki F: Plasma benzylamine oxidase activity in cerebrovascular disease. Eur Neurol 1990; 30:104-107.
16. Cockroft KM, Meistrell III M, Zimmerman GA, Risucci D, Bloom O, Cerami A, Tracey KJ: Cerebroprotective effects of aminoguanidine in a rodent model of stroke. Stroke 1996; 27:1393-1398.
17. Yu PH, Lai CT, Zuo DM: Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res 1997;22:615-620.
18. McCaman RE, McCaman MW, Hunt JM, Smith MS: Microdetermination of monoamine oxidase and 5-hydroxytryptophan decarboxylase activities in nervous tissues. J Neurochem 1965;12:15-23.
19. Hayes BE, Clarke DE: Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Commun Chem Pathol Pharmacol 1990;69:71-83.
20. Dahlhöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester P-O: Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-1285.
21. Buffoni F, Sicuteri F: Blood plasma benzylamine oxidase in migraine and hypertension. Ital J Biochem 1980;29:84-85.
22. Hayes BE, Ostrow PT, Clarke DE: Benzylamine oxidase in normal and atherosclerotic human aortae. Exp Mol Pathol 1983;38:243-254.
23. Lyles GA, Singh I: Vascular smooth muscle cell: A majorsource of the semicarbazide-sensitive amine oxidase of the rat aorta. J Pharm Pharmacol 1985;37:637-643.
24. Wibo M, Duong AT, Godfraind T: Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta. Eur J Biochem 1980;112:87-94.
25. Yu PH, Zuo DM, Davis BA: Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Biochem Pharmacol 1994;47:1055-1059.